Index of reports
> Cases with White Blood Cell Count Decreased (93)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 93 Next >>
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient:
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2012-04-27
Ribasphere
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-27
Other drugs received by patient: Prograf
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-04-13
PEG-Intron
Dosage: 0.4 ml, unk
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Brazil on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk, qw
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Ribavirin
Dosage: unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-02
End date: 2012-07-25
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Nausea, RED Blood Cell Count Decreased, Asthenia, Somnolence
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-02-23
Rebetol
Dosage: 200 mg, bid
Administration route: Oral
Rebetol
Dosage: 400 mg,
Indication: Hepatitis C
Start date: 2012-02-23
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-03-22
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased
Drug(s) suspected as cause:
Interferon Beta NOS
Dosage: 3 million iu, bid,6 days a week
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-02-03
PEG-Intron
Dosage: 100 ?g, qw
Indication: Hepatitis C
Start date: 2011-02-04
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-02-03
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2011-02-04
Other drugs received by patient: Candesartan Cilexetil; Lorfenamin; Norvasc; Urso 250; Lorfenamin
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
PEG-Intron
Dosage: unk unk, unknown
Start date: 2011-08-17
End date: 2012-04-03
PEG-Intron
Dosage: unk unk, unknown
End date: 2009-10-07
PEG-Intron
Dosage: 0.4 ?g, unknown
PEG-Intron
Dosage: 0.3 ?g, unknown
Ribavirin
Dosage: unk unk, unknown
End date: 2009-10-07
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
Ribavirin
Dosage: 200 mg, qd
Ribavirin
Dosage: unk unk, qd
Ribavirin
Dosage: unk unk, qd
Start date: 2011-08-17
End date: 2012-04-03
Ribavirin
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Other drugs received by patient: Epoetin Alfa
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: White Blood Cell Count Decreased, Anaemia, Dehydration, Food Craving, Blood Count Abnormal, Dizziness
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-24
Ribavirin
Dosage: unk unk, bid
Indication: Hepatitis C
Start date: 2012-02-24
Ribavirin
Dosage: unk unk, qd
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-14
Patient:
Reactions: White Blood Cell Count Decreased, Depression
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-16
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-13
End date: 2012-07-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-12
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-14
Patient:
Reactions: White Blood Cell Count Decreased, Anaemia, Alopecia, Dehydration, Pancytopenia, Neutropenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, unk
Start date: 2011-12-27
Ribavirin
Dosage: 1200 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-25
Other drugs received by patient: Rosuvastatin; Ramipril; Glucazide; Oxazepam; Premarin; Metformin HCL
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-13
Patient:
Reactions: White Blood Cell Count Decreased, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-06-26
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
Rebetol
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-02
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-05-30
End date: 2012-06-25
Other drugs received by patient: Xyzal; Lansoprazole; Cernilton; Flivas; Selbex
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2005-04-01
End date: 2006-03-03
Pegasys
Dosage: unk
Start date: 2012-03-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Rebetol
Dosage: 3 df, qd
Start date: 2012-03-22
Rebetol
Dosage: unk
Start date: 2005-04-01
End date: 2006-03-03
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-19
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Weight Decreased, Vomiting, Nausea, Dehydration, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, Anaemia, Blood Creatinine Increased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-03
Rebetol
Administration route: Oral
Start date: 2012-05-29
End date: 2012-07-03
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-05-17
Rebetol
Administration route: Oral
Start date: 2012-05-18
End date: 2012-05-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-11
Other drugs received by patient: Gasmotin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-07
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Orthostatic Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-04-06
PEG-Intron
Dosage: 1. microgram per kilogram per week
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-06-29
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-13
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-03-19
Rebetol
Dosage: 200mg/twice a week on monday and friday
Administration route: Oral
Start date: 2012-03-30
End date: 2012-04-05
Rebetol
Dosage: 200 mg, once
Administration route: Oral
Start date: 2012-04-20
End date: 2012-04-26
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-03-01
Rebetol
Dosage: 200mg/every other day
Administration route: Oral
Start date: 2012-04-06
End date: 2012-04-19
Rebetol
Dosage: 200 mg, qod
Administration route: Oral
Start date: 2012-04-06
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-04-27
End date: 2012-06-14
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-06-15
End date: 2012-06-29
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-02
End date: 2012-03-15
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-13
End date: 2012-04-06
Other drugs received by patient: Hirudoid; Primperan TAB; Loxonin; Levofloxacin; Zolpidem; Hirudoid; Allopurinol; Nexium
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: White Blood Cell Count Decreased, Dehydration, Paranasal Sinus Hypersecretion, Aptyalism, Influenza Like Illness
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 rp, unk
Ribavirin
Dosage: 1200/day
Victrelis
Dosage: 800 mg, tid (every 7-9 hours) with food
Administration route: Oral
Other drugs received by patient: Tylenol (Caplet); Vitamins (Unspecified); Aspirin; Benazepril Hydrochloride
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, White Blood Cell Count Decreased, Injection Site Erythema, Fatigue, Anaemia, Dizziness
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Start date: 2012-05-08
Victrelis
Dosage: 4 unk, tid
Start date: 2012-04-24
Other drugs received by patient: Ribasphere
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: White Blood Cell Count Decreased, Pruritus, Impaired Healing, Tooth Abscess, Skin Lesion, Tooth Extraction, Platelet Count Decreased, Memory Impairment
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-04
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-04
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-02
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Skin Injury, Vomiting, Drug Ineffective, Tooth Extraction, Tooth Infection, Headache, Haematemesis, Pain in JAW
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-05
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-05
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-03
End date: 2012-07-06
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-04
Patient:
Reactions: White Blood Cell Count Decreased, Fatigue, Impatience, Dizziness, Thirst, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-20
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-20
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-04
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Throat Irritation, Nausea, Dyspepsia, Emotional Disorder, Gastrooesophageal Reflux Disease, Crying
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-19
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-19
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-19
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-03
Patient:
Reactions: White Blood Cell Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-11
Ribasphere
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-02
Patient:
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Dysgeusia, Malaise, Haemolytic Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-22
PEG-Intron
Dosage: 1.5mcg/kg/week
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-05-11
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-04-18
End date: 2012-05-09
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-22
End date: 2012-04-17
Telavic
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-22
Other drugs received by patient: Marzulene-S; Nexium; Diovan; Azunol (Sodium Gualenate); Adalat CC; Mucosta
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased, RED Blood Cell Count Decreased, Blood Albumin Decreased, Platelet Count Decreased, Protein Total Decreased, Neutrophil Count Decreased
Drug(s) suspected as cause:
Interferon Beta NOS
Indication: Hepatitis C
Start date: 2010-08-16
End date: 2010-08-18
Interferon Beta NOS
Start date: 2010-08-23
End date: 2010-09-06
Interferon Beta NOS
Start date: 2010-09-21
End date: 2010-10-12
Interferon Beta NOS
Start date: 2010-08-19
End date: 2010-08-21
Interferon Beta NOS
Start date: 2010-09-07
End date: 2010-09-18
PEG-Intron
Dosage: unk unk, qw
Indication: Hepatitis C
Start date: 2010-10-15
End date: 2011-02-04
Rebetol
Administration route: Oral
Start date: 2010-10-01
End date: 2010-10-14
Rebetol
Dosage: 400 mg in the morning, 200 mg in the evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-08-16
End date: 2010-09-30
Rebetol
Administration route: Oral
Start date: 2010-10-15
Other drugs received by patient: Loxonin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-01
Patient:
Reactions: Drug Eruption, White Blood Cell Count Decreased, Depressive Symptom, Pancytopenia, Dysgeusia, Haemoglobin Decreased, Malaise, Diarrhoea, Epistaxis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100mcg/week
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-24
Rebetol
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-05
Other drugs received by patient: Marzulene-S; Mucosta; Urso 250; Famotidine
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient:
Reactions: Night Sweats, Abdominal Pain, Contusion, Chills, Wheezing, Pyrexia, Change of Bowel Habit, Constipation, Hyperhidrosis, Joint Stiffness, Hepatomegaly, Laboratory Test Abnormal, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Dizziness, Melaena, White Blood Cell Count Decreased, Dyspnoea, Hepatic Fibrosis, Haemorrhoids, Incorrect Dose Administered, Laceration, Hepatic Steatosis, Haemoglobin Decreased, Impaired Healing, Diarrhoea, Arthralgia, Insomnia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 180 microgram, qd
Pegasys
Dosage: 180mcg,once a week
Rebetol
Dosage: 1200 mg, qd
Victrelis
Dosage: 200mg,4tablets,three times a day
Other drugs received by patient: Allegra-D 12 Hour; Omeprazole; Milk Thistle; Zolpidem Tartrate; Citalopram Hydrobromide; Echinacea (Unspecified)
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: White Blood Cell Count Decreased, Pruritus, Pain, Platelet Count Decreased, Rash, Blister
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-19
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-19
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-08
End date: 2012-06-29
Page 1 Next >>
|